These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

107 related items for PubMed ID: 12601492

  • 1. Purpura fulminans in a child with combined heterozygous prothrombin G20210A and factor V Leiden mutations.
    Özbek N, Ataç FB, Verdi H, Kayıran SM.
    Ann Hematol; 2003 Feb; 82(2):118-120. PubMed ID: 12601492
    [Abstract] [Full Text] [Related]

  • 2. Postinfection purpura fulminans in a patient heterozygous for prothrombin G20210A and acquired protein S resistance.
    al-Ismail S, Collins P, Najib R, James-Ellison M, O'Hagan M.
    Pediatr Hematol Oncol; 1999 Feb; 16(6):561-4. PubMed ID: 10599098
    [Abstract] [Full Text] [Related]

  • 3. Severe protein S deficiency associated with heterozygous factor V Leiden mutation in a child with purpura fulminans.
    Dogan Y, Aygun D, Yilmaz Y, Kanra G, Secmeer G, Besbas N, Gurgey A.
    Pediatr Hematol Oncol; 2003 Feb; 20(1):1-5. PubMed ID: 12687747
    [Abstract] [Full Text] [Related]

  • 4. The risk of recurrent deep venous thrombosis among heterozygous carriers of both factor V Leiden and the G20210A prothrombin mutation.
    De Stefano V, Martinelli I, Mannucci PM, Paciaroni K, Chiusolo P, Casorelli I, Rossi E, Leone G.
    N Engl J Med; 1999 Sep 09; 341(11):801-6. PubMed ID: 10477778
    [Abstract] [Full Text] [Related]

  • 5. Clinical impact of factor V Leiden, prothrombin G20210A, and MTHFR C677T mutations among sickle cell disease patients of Central India.
    Nishank SS, Singh MP, Yadav R.
    Eur J Haematol; 2013 Nov 09; 91(5):462-6. PubMed ID: 23992124
    [Abstract] [Full Text] [Related]

  • 6. Risk of recurrent venous thrombosis in homozygous carriers and double heterozygous carriers of factor V Leiden and prothrombin G20210A.
    Lijfering WM, Middeldorp S, Veeger NJ, Hamulyák K, Prins MH, Büller HR, van der Meer J.
    Circulation; 2010 Apr 20; 121(15):1706-12. PubMed ID: 20368522
    [Abstract] [Full Text] [Related]

  • 7. Severe digital necrosis in an elderly patient with heterozygous factor V Leiden mutation.
    Patel GK, Morris E, Rashid MR, Anstey AV.
    Br J Dermatol; 2000 Dec 20; 143(6):1302-5. PubMed ID: 11122039
    [Abstract] [Full Text] [Related]

  • 8. Combined genetic defect (homogeneity for factor V Leiden and heterogeneity for prothrombin G20210A allele), in a young patient, with recurrent deep vein thrombosis and serious postphlebitic syndrome--a case report.
    Mitsis M, Ioannou H, Eleftheriou A, Nousias V, Basioukas C, Kakosimos G, Batsis C, Vartholomatos G.
    Angiology; 2000 Apr 20; 51(4):325-9. PubMed ID: 10779003
    [Abstract] [Full Text] [Related]

  • 9. Combined heterozygosity of factor V leiden and the G20210A prothrombin gene mutation in a patient with cerebral cortical vein thrombosis.
    Liu XY, Gabig TG, Bang NU.
    Am J Hematol; 2000 Jul 20; 64(3):226-8. PubMed ID: 10861823
    [Abstract] [Full Text] [Related]

  • 10. Risk of venous thrombosis in carriers of the prothrombin G20210A variant and factor V Leiden and their interaction with oral contraceptives.
    Aznar J, Vayá A, Estellés A, Mira Y, Seguí R, Villa P, Ferrando F, Falcó C, Corella D, España F.
    Haematologica; 2000 Dec 20; 85(12):1271-6. PubMed ID: 11114134
    [Abstract] [Full Text] [Related]

  • 11. Livedoid vasculiltis associated with a double heterozygous Factor V Leiden and prothrombin G20210A gene mutations.
    Khenifer S, Thomas L, Balme B, Dalle S.
    Clin Exp Dermatol; 2009 Dec 20; 34(8):e811-3. PubMed ID: 19793098
    [Abstract] [Full Text] [Related]

  • 12. Association of the prothrombin G20210A mutation with factor V Leiden in a midwestern American population.
    Bavikatty NR, Killeen AA, Akel N, Normolle D, Schmaier AH.
    Am J Clin Pathol; 2000 Aug 20; 114(2):272-5. PubMed ID: 10941343
    [Abstract] [Full Text] [Related]

  • 13. Factor V Leiden mutation in Turkish patients with homozygous cystathionine beta-synthase deficiency.
    Kalkanoğlu HS, Coşkun T, Aydoğdu SD, Tokatli A, Gürgey A.
    J Inherit Metab Dis; 2001 Jun 20; 24(3):367-9. PubMed ID: 11486902
    [Abstract] [Full Text] [Related]

  • 14. AB0 blood group and risk of venous or arterial thrombosis in carriers of factor V Leiden or prothrombin G20210A polymorphisms.
    Miñano A, Ordóñez A, España F, González-Porras JR, Lecumberri R, Fontcuberta J, Llamas P, Marín F, Estellés A, Alberca I, Vicente V, Corral J.
    Haematologica; 2008 May 20; 93(5):729-34. PubMed ID: 18387978
    [Abstract] [Full Text] [Related]

  • 15. Combined effect of factor V Leiden and prothrombin 20210A on the risk of venous thromboembolism--pooled analysis of 8 case-control studies including 2310 cases and 3204 controls. Study Group for Pooled-Analysis in Venous Thromboembolism.
    Emmerich J, Rosendaal FR, Cattaneo M, Margaglione M, De Stefano V, Cumming T, Arruda V, Hillarp A, Reny JL.
    Thromb Haemost; 2001 Sep 20; 86(3):809-16. PubMed ID: 11583312
    [Abstract] [Full Text] [Related]

  • 16. Factor V Leiden and prothrombin G20210A mutations in Thai patients awaiting kidney transplant.
    Arnutti P, Nathalang O, Cowawintaweewat S, Prayoonwiwat W, Choovichian P.
    Southeast Asian J Trop Med Public Health; 2002 Dec 20; 33(4):869-71. PubMed ID: 12757241
    [Abstract] [Full Text] [Related]

  • 17. Coexistence of factor V G1691A and factor II G20210A gene mutations in a thrombotic family is associated with recurrence and early onset of venous thrombosis.
    Gemmati D, Serino ML, Moratelli S, Tognazzo S, Ongaro A, Scapoli GL.
    Haemostasis; 2001 Dec 20; 31(2):99-105. PubMed ID: 11684865
    [Abstract] [Full Text] [Related]

  • 18. Clinical manifestations of the prothrombin G20210A mutation in children: a pediatric coagulation consortium study.
    Young G, Manco-Johnson M, Gill JC, Dimichele DM, Tarantino MD, Abshire T, Nugent DJ.
    J Thromb Haemost; 2003 May 20; 1(5):958-62. PubMed ID: 12871361
    [Abstract] [Full Text] [Related]

  • 19. Concomitant heterozygous factor V Leiden mutation and homozygous prothrombin gene variant (G20210A) in patient with cerebral venous thrombosis.
    Kurkowska-Jastrzebska I, Wicha W, Dowzenko A, Vertun-Baranowska B, Pytlewski A, Bogusławska R, Członkowska A.
    Med Sci Monit; 2003 May 20; 9(5):CS41-5. PubMed ID: 12761462
    [Abstract] [Full Text] [Related]

  • 20. Association of maternal and/or fetal factor V Leiden and G20210A prothrombin mutation with HELLP syndrome and intrauterine growth restriction.
    Schlembach D, Beinder E, Zingsem J, Wunsiedler U, Beckmann MW, Fischer T.
    Clin Sci (Lond); 2003 Sep 20; 105(3):279-85. PubMed ID: 12725641
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.